NEWS – FDA grants Breakthrough designation for Celeste® specialized phototherapy.
Learn more about Celeste specialized phototherapy as the only light-related therapy to receive this FDA recognition. Be among the first to know when our pivotal study recruiting begins. Sign Up >
NEWS – FDA grants Breakthrough designation for specialized phototherapy.
Learn more about Celeste specialized phototherapy as the only light-related therapy to receive this FDA recognition. Be among the first to know when our pivotal study recruiting begins. Sign Up >
ADDRESSING MAJOR UNMET NEEDS
A Breakthrough Therapy for People Living with Parkinson’s Disease
Specialized phototherapy addresses both motor and non-motor symptoms
Over 11 million people worldwide live with Parkinson’s disease (PD), a number that is projected to double over the next 20 years. As with so many other neurodegenerative diseases, there have been no major breakthroughs in Parkinson’s disease in decades.
Our personalized at-home device promises to be one of the most significant therapeutic breakthroughs in Parkinson’s disease in decades. We have seen large improvements in our proof-of-concept studies – especially in addressing major unmet needs in Parkinson’s. We are initiating a pivotal trial of our key product, Celeste® specialized phototherapy, to confirm safety and sustained efficacy.
Despite the efficacy of dopaminergic drugs, people with PD continue to experience difficulties with unresolved motor symptoms and non-motor symptoms (e.g., sleep disorders, fatigue, and mood and cognitive problems). Impaired function significantly reduces quality of life for many, often preventing those living with PD from working, exercising, socializing, and doing the things they want to do.
We invite you to join us to improve the lives of individuals suffering from neurodegenerative diseases.
Seeing Specialized Phototherapy Clearly
Our non-invasive specialized phototherapy is well on its way to becoming a physician-prescribed standard of care.
When it comes to motor and non-motor symptoms of Parkinson’s, here’s what we’re seeing so far.
PROMISING RESULTS
and enjoyed improved quality of life.
NON-INVASIVE
LIFESTYLE FRIENDLY PROTOCOL
Trending Topics
Recruitment for Non-Invasive Parkinson’s Phase3/Pivotal Study Slated for December
Recruitment for Non-Invasive Parkinson’s Phase 3/Pivotal Study Slated for December Non-invasive Parkinson’s therapeutic device moves one step closer to FDA clearance, with important potential non-motor and motor improvements for patients. The maker of the widely...
How Parkinson’s Affects Sleep and Vice-Versa
When most people think of Parkinson’s Disease (PD), the first symptom to come to mind are physical tremors and other movement symptoms. However, most people with Parkinson’s experience a wide range of non-motor symptoms that can often be more disruptive to their daily...
Care for the caregivers
“What would I do without my caregiver?” Many people with Parkinson’s disease ask themselves some form of this question every single day. Caregivers come in all shapes and forms, but they all have one thing in common: The work they do is absolutely critical. But it’s...
“Breaking Through the FDA” (Biosphere, 2021)
Innovative medical devices and diagnostics can get to patients and providers sooner under the U.S. Food and Drug Administration’s (FDA) Breakthrough Device Program. The program provides a special regulatory Breakthrough Device Designation for medical products that...
PhotoPharmics brings renowned experts in Parkinson’s disease and other neurodegenerative diseases to advisory board
View full press release on Businesswire. PhotoPharmics brings renowned experts in Parkinson’s disease and other neurodegenerative diseases to advisory board Breakthrough device innovator will leverage the expertise of leading authorities to bolster the company’s...